20 Participants Needed

Gigstride Device for Difficulty Walking

AC
Overseen ByAkhil Chhatre, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Johns Hopkins University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

What is the purpose of this trial?

For patients with lower extremity deficits, the investigator(s) would like to assess implementing use of Gigstride ambulatory device to assess the following: * Patient satisfaction with use of ambulatory device * Effects of Gigstride device utilization on kinetics, biomechanics * Effects of Gigstride device utilization on walking speed, stair speed, stability

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications.

What data supports the effectiveness of the Gigstride Device treatment for difficulty walking?

Research on similar devices, like a biofeedback device for improving heel-to-toe gait in seniors, shows that such devices can effectively classify and improve walking patterns with high accuracy. Additionally, a weight-relieving walker has been shown to significantly aid patients with severe walking difficulties, suggesting that devices designed to assist with walking can be beneficial.12345

How is the Gigstride Device treatment different from other treatments for difficulty walking?

The Gigstride Device is unique because it combines real-time gait analysis with biofeedback to help improve walking patterns, unlike traditional physiotherapy which is limited to clinical settings. It uses sensors to detect and classify step quality, providing immediate feedback to the user, which can enhance rehabilitation outside of a clinical environment.26789

Research Team

AC

Akhil Chhatre, MD

Principal Investigator

Johns Hopkins University

Eligibility Criteria

This trial is for adults over 18 with walking difficulties due to lower limb problems like osteoarthritis, spinal issues, multiple sclerosis, or foot drop. They should be using mobility aids and able to wear laced shoes. Participants must have had treatment for their mobility issue and provide consent.

Inclusion Criteria

I am older than 18.
I have been treated for difficulty moving due to conditions like arthritis or MS.
I have given my written consent to participate.
See 2 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants use the Gigstride ambulatory device to perform tasks and complete a questionnaire

1 hour
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 year

Treatment Details

Interventions

  • Gigstride Device
Trial Overview The study tests the Gigstride ambulatory device on patients with limited mobility in their legs. It will measure patient satisfaction, changes in walking mechanics, speed on flat surfaces and stairs, as well as overall stability while using the device.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: Use of Gigstride Ambulatory DeviceExperimental Treatment1 Intervention
The participant will be use the Gigstride ambulatory device to perform the following tasks: * Walk a different distances to assess speed and fatigue * Perform functional mobility tasks (sit-to-stand, stand-to sit, stand-pivots, etc.) The participants will then be asked to fill out a questionnaire, "Gigstride Clinical Trial Questionnaire" that will be used for qualitative data, such as ease of use and comfortability with using the device. The overall amount of time for the evaluation and questionnaire will take approximately 30 minutes to 1 hour.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Johns Hopkins University

Lead Sponsor

Trials
2,366
Recruited
15,160,000+

Gigstride Corporation

Collaborator

Trials
1
Recruited
20+

Findings from Research

The Ambulosono wearable sensor system demonstrated high accuracy and reliability in measuring gait parameters, with a mean percentage error of less than 10% compared to true values during tests with 15 participants.
In head-to-head comparisons, the Ambulosono system outperformed the iPod touch sensor system, indicating it could be a cost-effective alternative for use in clinical rehabilitation programs.
Development and Validation of Ambulosono: A Wearable Sensor for Bio-Feedback Rehabilitation Training.Chomiak, T., Sidhu, AS., Watts, A., et al.[2020]
A new device has been developed to distinguish between healthy heel-to-toe walking and shuffling gait in older adults, providing real-time feedback to improve gait quality.
In a validation study, the device achieved an impressive accuracy of 84.1% in classifying gait types, with high sensitivity (92.4%), indicating it could be a valuable tool for gait rehabilitation in clinical settings.
Design and Validation of a Biofeedback Device to Improve Heel-to-Toe Gait in Seniors.Vadnerkar, A., Figueiredo, S., Mayo, NE., et al.[2018]
The SHIMMER wireless sensor platform shows excellent agreement with the established CODA motion analysis system for measuring gait parameters, indicating its reliability for ambulatory monitoring.
With high correlation in stride, swing, and stance times during walking and running trials, the SHIMMER is a promising, cost-effective tool for assessing gait in the aging population.
SHIMMER: A new tool for temporal gait analysis.O'Donovan, KJ., Greene, BR., McGrath, D., et al.[2020]

References

Development and Validation of Ambulosono: A Wearable Sensor for Bio-Feedback Rehabilitation Training. [2020]
Design and Validation of a Biofeedback Device to Improve Heel-to-Toe Gait in Seniors. [2018]
SHIMMER: A new tool for temporal gait analysis. [2020]
Smart Offloading Boot System for Remote Patient Monitoring: Toward Adherence Reinforcement and Proper Physical Activity Prescription for Diabetic Foot Ulcer Patients. [2023]
Self-propelled weight-relieving walker for gait rehabilitation. [2019]
A treadmill apparatus and harness support for evaluation and rehabilitation of gait. [2019]
Real-time gait event detection using wearable sensors. [2013]
Agreement between temporal and spatial gait parameters from an instrumented walkway and treadmill system at matched walking speed. [2022]
Effects of using assistive devices on the components of the modified instrumented timed up and go test in healthy subjects. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity